Quarterly EPS Estimate For Diplomat Pharmacy, Inc. (NYSE:DPLO) Cited At $0.24


The average EPS estimate for Diplomat Pharmacy, Inc. (NYSE:DPLO) for the three months ending 2016-12-31 is given as $0.24.

You find that 7 days ago, the average EPS estimate on the stock was $0.24, while for the 30 days ago the average EPS estimate stood at $0.24.

If you look back further, you see that the average EPS estimate for Diplomat Pharmacy, Inc. (NYSE:DPLO) 60 days ago was given as 0.24, while EPS estimate 90 days ago was quoted at $0.24.

The change in the stock’s EPS estimate over the last 7 days works out to -0.02%.

EPS estimate revisions

Over the last 7 days, EPS estimates for Diplomat Pharmacy, Inc. (NYSE:DPLO) have been revised up 0 times. In the same period, the EPS estimate has been revised down 2 times.

In the last 30 days, the stock has had its EPS estimate revised up 0 and it has been revised up 0 times over the last 60 days.

Up revisions in the last 90 days are 0 and up revisions in the last 120 days are 1.

But for the last 18 days, the company has seen its EPS revised up 0 times, offset by 4 down revisions in the same period.

The down revisions of EPS in last 30, 60, 90 and 120 days were 2, 2, 2 and 4.

What About EPS Surprises

Analysts predicted EPS of $0.24 for Diplomat Pharmacy, Inc. (NYSE:DPLO) for the period ended 2. But the company ended up posting actual EPS of $0.23 on 2016-08-09. The EPS estimate cited was worked out based on 10 estimates that analysts had issued on the stock.

Therefore, Diplomat Pharmacy, Inc. (NYSE:DPLO) posted EPS surprise of $0.02 per share in dollar terms, which works out to 9.52%. The standard deviation of the actual EPS reported by the company and the average EPS estimate immediately before the earnings were released works out to $0.01.

Quarterly Sales Estimates

For the fiscal year 2017, the mean and median annual sales estimates for the company are given as $1570.023 and $1570.023. The estimates are based on the projections of 2 analysts.

So far, the highest annual sales estimate for Diplomat Pharmacy, Inc. (NYSE:DPLO) stands at$1608.658. That compares with the lowest annual sales estimate of $1531.389. Calculating the standard deviation of the extreme annual sales estimates leads you to 54.637%.

Annual sales estimate adjustments

In the last 7 days, 2 analysts have raised their annual sales estimates for the company. But over the same period, 2 analysts have trimmed their annual sales estimates.

With that, you find that the percentage change in mean annual sales estimate in the last 7 days works out to -3.382%.

Over the last one month, though, 2 analysts moved to raise their sales estimates for Diplomat Pharmacy, Inc. (NYSE:DPLO). That compares with 2 analysts who cut their sales estimate for the company in the same period. That leads you to -3.382% as the mean sales estimate change over the last one month.

If you look back further, you see that over the last three months, 2 analysts have moved raise their sales estimates Diplomat Pharmacy, Inc. (NYSE:DPLO). That offset by 2 analysts who in the same period lowered their sales estimates for the stock. That works out to percentage change in mean sales estimate of -3.382% over a period of three months.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 14 times, 1 visits today)